NASDAQ:CHNG - US15912K1007 - Common Stock
CHNG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. CHNG has a bad profitability rating. Also its financial health evaluation is rather negative. CHNG is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.8% | ||
ROE | N/A | ||
ROIC | 1.09% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 3.43% | ||
PM (TTM) | -2.2% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.36 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.23 | ||
Quick Ratio | 1.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.57 | ||
Fwd PE | 15.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 16.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
27.49
+0.07 (+0.26%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.57 | ||
Fwd PE | 15.89 | ||
P/S | 2.58 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.74 | ||
P/tB | N/A | ||
EV/EBITDA | 16.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.8% | ||
ROE | N/A | ||
ROCE | N/A | ||
ROIC | 1.09% | ||
ROICexc | N/A | ||
ROICexgc | 9.33% | ||
OM | 3.43% | ||
PM (TTM) | -2.2% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.36 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.23 | ||
Quick Ratio | 1.23 | ||
Altman-Z | 1.12 |